ArticleResuscitation plus2025
Predictive performance and temporal dynamics of national early warning score 2 (NEWS2) in detecting clinical deterioration in general ward: A large-scale validation study in Singapore.
Article in Resuscitation plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic Value of the National Early Warning Score Combined with Nutritional and Endothelial Stress Indices for Mortality Prediction in Critically Ill Patients with Pneumonia.Medicina (Kaunas, Lithuania) · 2026Article
- Clinical characteristics of pyogenic liver abscess patients with multiple organ dysfunction syndrome and development and validation of a predictive model.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The National Early Warning Score 2 (NEWS2) is widely used in electronic health records to identify patients at risk of clinical deterioration. However, evidence of its performance in Asian populations and across varying prediction time windows remains limited. Methods: In this retrospective validation study, we analysed 58,809 patient encounters from a 1700-bed tertiary hospital in Singapore. We evaluated NEWS2's discrimination (area under the receiver operating characteristic curve [AUROC]) and calibration for predicting clinical deterioration - defined as death, unanticipated intensive care unit/high dependency (ICU/HD) admission, or code blue activation - within 24 h and across multiple time windows (4 to 72 h), using 100 bootstrap iterations. Results: Event rates were 0.75 % for clinical deterioration, 0.51 % for death, 0.24 % for unanticipated ICU/HD admission and 0.05 % for code blue activation within 24 h. NEWS2 demonstrated strong overall discriminative performance for clinical deterioration (AUROC 0.898, 95 % CI: 0.881-0.915). Discrimination was excellent for mortality (AUROC 0.963, 95 % CI: 0.952-0.974), moderate for code blue activation (AUROC 0.795, 95 % CI: 0.714-0.876) and modest for unanticipated ICU/HD admission (AUROC 0.761, 95 % CI: 0.715-0.808). Calibration was excellent for mortality, but poor for unanticipated ICU/HD admission and code blue activation. Temporal analysis revealed consistent performance across different time windows for mortality prediction, with varying patterns for other outcomes. Conclusions: NEWS2 reliably predicts clinical deterioration and mortality in an Asian tertiary care setting. However, its predictive performance for unanticipated ICU/HD admission and code blue activation remains limited, suggesting the need for further model adjustment to enhance its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.